A Real-World Single-Center Report on the Effectiveness and Safety of Blinatumomab Treatment on Pediatric Acute Lymphoblastic Leukemia in China
BLOOD(2023)
摘要
Background: Studies overseas have demonstrated blinatumomab benefits pediatric acute lymphoblastic leukemia (ALL), but the experience is limited in China.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要